Diseases, Conditions, Syndromes

Treatment improves cognition in Down Syndrome patients

A new hormone treatment improved the cognitive function of six men with Down Syndrome by 10-30 percent, scientists said Thursday, adding the "promising" results may raise hopes of improving patients' quality of life.

Parkinson's & Movement disorders

Is it Parkinson's? These 10 signs could tell

Parkinson's disease can be hard for the average person to identify, but 10 warning signs may offer an early clue that you or a loved one may be developing the disease.

Diseases, Conditions, Syndromes

Most patients regain taste, smell following COVID-19

Nearly nine in 10 patients reporting a COVID-19-related smell or taste dysfunction completely recovered within two years, although recovery took more than six months for 10.9 percent of patients, according to a research letter ...

Diseases, Conditions, Syndromes

Could loss of smell from COVID-19 create future 'dementia wave?'

A review of studies about the effect of SARS-CoV-2—the virus that causes COVID-19—on the olfactory system introduces questions about whether loss of smell associated with COVID-19 infection may increase the risk of developing ...

Diseases, Conditions, Syndromes

Long-lasting loss of smell, taste in 5% of COVID cases: study

Around five percent of people who have had COVID-19 develop long-lasting problems with their sense of smell or taste, a large study said Thursday, potentially contributing to the burden of long COVID.

Diseases, Conditions, Syndromes

Suffering from a smell disorder? Eat chili, menthol and rapeseed oil

Smell plays a key role in our ability to enjoy food. However, many people suffer from a lost, impaired or distorted sense of smell, and this can affect both their health and quality of life, says a new study from Aarhus University.

Diseases, Conditions, Syndromes

COVID: Six ways long-term smell loss can affect us

Early in the pandemic, multiple studies showed that about half of people with COVID lost their sense of smell (called anosmia) at some point during the course of infection. Roughly an additional 20% to 35% experienced a clinical ...

page 6 from 32